Psychology, Clinical Psychology, Psychiatry and Mental health, Neuropsychology and Physiological Psychology
21
Scopus Publications
485
Scholar Citations
14
Scholar h-index
16
Scholar i10-index
Scopus Publications
Circadian Rhythm and Substance Use in Adults: A Scoping Review of Sex-Based Differences Julia E. Marquez-Arrico, Ana Adan Current Addiction Reports, 2026 Abstract Purpose of Review Circadian rhythms regulate sleep–wake cycles and other biological and behavioral processes, and are known to interact bidirectionally with substance use and substance use disorders (SUD). Emerging evidence suggests these interactions being modulated by sex-based biological and psychosocial factors, yet the research from a sex-specific perspective remains limited. This review analyzes and synthesizes the existing evidence on sex-related differences in circadian rhythm among adults with substance use and SUD. Recent Findings Following the PRISMA-ScR framework, we searched seven databases for primary studies published in the last decade reporting circadian parameters (e.g., sleep quality, chronotype) with sex-related outcomes in adults with substance use/SUD. Twenty-three eligible studies were selected, and data were extracted and synthesized narratively. Women consistently exhibited poorer sleep quality, higher insomnia symptoms, and stronger associations between substance use (especially alcohol and cannabis) and circadian disruption. Despite these patterns, most studies treated sex as a secondary variable or predictor, and objective circadian measures (e.g., actigraphy, melatonin) were rarely employed. Circadian differences were also evident, with evening preference linked to greater SUD risk in men, while social jetlag was more strongly associated with alcohol misuse in women. Summary Sex differences are reported in sleep and circadian characteristics among people with substance use/SUD, with women exhibiting greater problems. Current research is mainly considering sex as a secondary variable and there is a lack of sex-stratified data, which might be masking sex-based differences and leading to inaccurate conclusions about efficacy, safety of treatments, or risk factors. A gender-informed approach is essential for advancing in prevention and treatment strategies.
Gender-Sensitive Coping–Well-Being Profiles Associated with Alcohol and Cannabis Co-Use Among Young Adult Women Julia E. Marquez-Arrico, Jana Subirana Navarro Substance Use and Misuse, 2026 BACKGROUND: Coping strategies and health-related quality of life (HRQoL) are critical psychosocial determinants of substance use risk during emerging adulthood. These factors may be particularly salient among young women due to gendered emotional and interpersonal stressors. However, much substance use research remains gender-neutral, often failing to account for unique developmental factors influencing women. OBJECTIVE: This study aims to identify gender-sensitive coping-well-being profiles associated with alcohol and cannabis co-use among young adult women and examine whether specific coping strategies and HRQoL domains predict hazardous involvement. METHODS: = 21.3). Validated self-report measures included the Alcohol Use Disorders Identification Test (AUDIT), Cannabis Abuse Screening Test (CAST), Coping Strategies Inventory (CSI), and the 36-Item Short Form Health Survey (SF-36). Analyses utilized ANOVA/MANCOVA, regression models, and two-step cluster analysis. RESULTS: Alcohol use was prevalent (92.5%), with 25% reporting alcohol and cannabis co-use. Greater cannabis-related risk was associated with higher alcohol involvement, increased self-critical coping, and higher scores on SF-36 Bodily Pain. Three distinct profiles emerged: High-Risk (co-use, elevated self-criticism, low general health, and reduced social support), Protective (strong problem-solving, social support, and higher HRQoL in key psychosocial domains), and Latent Vulnerability (low substance use despite poor coping resources, high self-criticism, and reduced mental well-being). CONCLUSIONS: Coping strategies and perceived well-being differentiate women's substance involvement beyond usage frequency. Gender-sensitive prevention should address self-critical coping and HRQoL, even among women with low current use but high psychosocial vulnerability. Psychosocial profiling may improve early identification for co-use risk.
Neurocognitive and clinical profile of male patients with substance use disorder in early remission phase with and without comorbid depression Julia E. Marquez-Arrico, Judit Catalán-Aguilar, José Francisco Navarro, Ana Adan Progress in Neuro Psychopharmacology and Biological Psychiatry, 2024 Substance Use Disorder (SUD) represents one of the most frequent conditions worldwide which commonly coexists with major depressive disorder (MDD). This comorbidity (SUD + MDD) is one of the most prevalent with patients showing certain social and clinical characteristics that could lead to a worsening of their cognitive performance. However, despite these particularities, only a few studies have addressed the possible differences in cognitive performance between patients with SUD + MDD compared with those with SUD-only patients. Therefore, the aim of this study is to examine the clinical and cognitive profile of patients with SUD + MDD vs. SUD-only who are in early remission phase. For this purpose, 271 male patients underwent a clinical and neuropsychological assessment (SUD + MDD group: N = 101; SUD-only group: N = 170). Results indicated that SUD + MDD patients showed worse cognitive performance than SUD in visuospatial reasoning, verbal memory and learning, recognition, and processing speed even after a 3-month period of abstinence. Furthermore, these patients exhibited more self-reported prefrontal symptoms, as well as worse social and clinical conditions. This study indicates that the neurocognitive and clinical profile of patients with SUD + MDD could represent a risk since their characteristics have been associated with poorer recovery and prognosis. Our results could be helpful in clinical practice highlighting the need for cognitive remediation strategies in these populations, providing information that would allow the implementation of more appropriate treatments and preventive strategies.
Could Periodontitis Increase the Risk of Suffering from Pancreatic Cancer?—A Systematic Review Cecilia Fabiana Márquez-Arrico, Francisco Javier Silvestre, Julia Elena Marquez-Arrico, Javier Silvestre-Rangil Cancers, 2024 (1) Background: The relationship between periodontitis and systemic pathologies continues to grow. Recently, the presence of periodontal pathogens has been linked to an increased risk of pancreatic cancer (PC) and its mortality. Thus, a systematic review is needed to identify whether an association between the two diseases can be established. The objective of this review is to elucidate the mechanisms responsible for this association. (2) Methods: A systematic review was carried out using three databases (PubMed, Embase and Scopus) with the following keywords “Periodontitis AND pancreatic cancer”. A total of 653 articles were retrieved; before selection and screening, the inclusion and exclusion criteria were defined, resulting in a total of 13 articles being included in the review. (3) Results: The increase in low-grade systemic inflammation, pH changes, and the cytotoxicity of certain periodontopathogenic bacteria were found in the scientific literature reviewed as mechanisms linking periodontitis with the risk of PC. (4) Conclusions: Through this systematic review, we have seen how periodontitis can be related to PC and how it worsens its prognosis. Knowing the behavior of periodontopathogenic bacteria and the influence they have on our immune and inflammatory system may help to achieve an interdisciplinary approach to both pathologies.
Circadian rhythmicity in schizophrenia male patients with and without substance use disorder comorbidity Ana Adan, Julia E. Marquez-Arrico, Laura Río-Martínez, José Francisco Navarro, Antonio Martinez-Nicolas European Archives of Psychiatry and Clinical Neuroscience, 2024 Circadian rhythmicity is associated to clinical variables that play an important role in both schizophrenia (SZ) and substance use disorders (SUD), although the characteristics of the coexistence of these two diagnoses (SZ +) remain mostly unknown. Hence, we studied a sample of 165 male patients divided in three groups each of 55, according to their diagnoses (SZ + , SZ, and SUD), as well as a healthy control (HC; n = 90) group. Alongside with sociodemographic and clinical variables, circadian rhythms were registered through a sleep–wake data structured interview, a circadian typology questionnaire, and distal skin temperature (DST) using the Thermochron iButton every 2 min during 48 h. Analyses showed that SZ + and SZ patients presented a longer sleep (delay in wake-up time) and mostly an intermediate circadian typology, while SUD patients slept less hours, displaying a morning typology. The DST showed the highest daily activation and stability for the SUD group, even when compared with the HC group. The presence of schizophrenia (SZ + and SZ) was related to a DST pattern with a reduced amplitude determined by a wakefulness impairment, which was more pronounced for SZ patients whose sleep period was adequate. The assessment of circadian rhythms in under treatment male patients with SZ should be focused on the diurnal period as a possible marker of either treatment adherence or patient's recovery, irrespective of the presence of a comorbid SUD. Further research with additional objective measures may provide knowledge transferable to therapeutic strategies and could be useful to establish possible endophenotypes in the future.
Neuropsychological functioning of patients with major depression or bipolar disorder comorbid to substance use disorders: A systematic review Nuria Miguel, Julia E. Marquez-Arrico, Mercè Jodar, José Francisco Navarro, Ana Adan European Neuropsychopharmacology, 2023 Major depression disorder (MDD) and bipolar disorder (BD) are usual comorbidities in patients with substance use disorders (SUD), a condition known as dual disorder (DD). MDD, BD and SUD are associated with cognitive impairment, potentially leading to a greater functional impairment in the context of DD. OBJECTIVES: To review the existing data on the cognitive impairment in DD patients with comorbid MDD or BD, considering the influence of the depressive symptomatology. METHODS: Following the PRISMA protocol 19 studies were selected from the last 17 years, 13 of which focused on BD, five on MDD and one included both diagnoses. RESULTS: Studies based in BD+SUD showed that the most affected cognitive domains were attention and executive functions, but not all of them found a greater impairment due to the comorbidity. While fewer studies were found for depression, MDD+SUD works point to a similar impairment cognitive pattern. Furthermore, depression improvement could be associated to better cognitive performance. LIMITATIONS: More standardized research is needed regarding the influence of depression on cognitive performance of DD patients, especially on those with comorbid MDD. Factors such as main substance, abstinence, or MDD/BD-related variables should be considered. Unstudied factors, like gender or circadian rhythms, are proposed to improve knowledge in this area. CONCLUSIONS: Current studies suggest that DD could potentiate cognitive impairment in BD, MDD and SUD. However, additional research is needed to improve the understanding of comorbidity to apply more individualized therapies in the treatment of these patients, considering the interference of their neurocognitive functioning.
Patients with Schizophrenia Showed Worse Cognitive Performance than Bipolar and Major Depressive Disorder in a Sample with Comorbid Substance Use Disorders Julia E. Marquez-Arrico, Alvaro Gonzalez-Sanchez, José Francisco Navarro, Rafael Penadés, Ana Adan Journal of Clinical Medicine, 2022 Comorbidity of substance use disorders (SUD) and severe mental illness (SMI) is highly frequent in patients, the most common diagnoses being schizophrenia (SZ), bipolar disorder (BD) and major depressive disorder (MDD). Since comorbidity has its own clinical features, and neurocognitive functioning is not always similar to psychiatric symptoms the present study explores the cognitive performance of patients with dual disorders. A neuropsychological battery of tests was used to assess 120 under treatment male patients, 40 for each group considered (SZ + SUD, BD + SUD and MDD + SUD) who were mainly polyconsumers. Significant differences (with premorbid IQ as a covariate) were found among the groups, with SZ + SUD having a worse performance in attention, verbal learning, short term memory and recognition. The consideration of a global Z score for performance evidenced an impaired neurocognitive pattern for SZ + SUD compared with BD + SUD and MDD + SUD. According to norms, all patients showed difficulties in verbal learning, short-term memory and recognition. Our research indicated that the neurocognitive functioning of dual disorder patients was influenced by the comorbid SMI, with SZ + SUD presenting major difficulties. Future studies should thoroughly explore the role of such difficulties as indicators or endophenotypes for dual schizophrenia disorders, and their usefulness for prevention and treatment.
Protocol for Characterization of Addiction and Dual Disorders: Effectiveness of Coadjuvant Chronotherapy in Patients with Partial Response Ana Adan, José Francisco Navarro, and Journal of Clinical Medicine, 2022 This protocol aims to characterize patients with dual disorders (DD; comorbid major depression and schizophrenia) compared with patients with only a diagnosis of substance use disorder (SUD) and those with only a diagnosis of severe mental illness (SMI; major depression and schizophrenia), evaluating clinical and personality characteristics, circadian rhythmic functioning, genetic polymorphism and neuropsychological performance in order to obtain a clinical endophenotype of differential vulnerability for these diagnostic entities. Patients will be divided into three groups: DD (45 men with comorbid schizophrenia, 45 men and 30 women with major depression), SUD (n = 90, with a minimum of 30 women) and SMI males (45 with schizophrenia, 45 with major depression). All patients will be under treatment, with at least three months of SUD abstinence and/or with SMI in remission or with stabilized symptoms. Outpatients of both sexes with insufficient restoration of circadian rhythmicity with SUD (n = 30) and dual depression (n = 30) will be asked to participate in a second two-month study, being alternately assigned to the condition of the chronobiological adjuvant approach to the treatment of regular hour habits and exposure to light or to the usual treatment (control). The effect of the intervention and patient compliance will be monitored with a Kronowise KW6® ambulatory device during the first two weeks of treatment and again at weeks 4 and 8 weeks. After completing the evaluation, follow-up of the clinical evolution will be carried out at 3, 6 and 12 months. This project will allow us to analyze the functional impact of DD comorbidity and to develop the first study of chronobiological therapy in the treatment of SUD and dual depression, with results transferable to the clinical setting with cost-effective recommendations for a personalized approach.
Circadian Functioning and Quality of Life in Substance Use Disorder Patients With and Without Comorbid Major Depressive Disorder Iman Hashemzadeh, Julia E. Marquez-Arrico, Kosar Hashemzadeh, José Francisco Navarro, Ana Adan Frontiers in Psychiatry, 2021 Aim: Although a relationship between circadian disruption and development of several psychiatric disorders, such as major depressive disorder (MDD) and substance use disorder (SUD), has been observed, knowledge on this area is scarce yet. Therefore, this study aims to analyze the circadian functioning and quality of life (QOL) in SUD patients with and without comorbid MDD, two highly prevalent clinical entities with difficult therapeutic management.Methods: One hundred sixty-three male patients under treatment, 81 with SUD and 82 with SUD comorbid major depressive disorder (SUD + MDD), were evaluated. For the circadian functioning assessment, we calculated Social Jet Lag (SJL) and used the reduced Morningness–Eveningness Questionnaire (rMEQ) and the Pittsburgh Sleep Quality Index (PSQI). QOL was measured using the shortened version of the World Health Organization's Quality of Life Questionnaire (WHOQOL-BREF). We collected sociodemographic and clinical variables to evaluate their possible influence on the circadian functioning. Intergroup differences among the variables were examined by different analyses of covariance (ANCOVA and MANCOVA). The possible relationships of quantitative clinical variables with rMEQ, PSQI, and WHOQOL-BREF were explored using bivariate correlation analysis.Results: Lower SJL appears in the SUD + MDD group compared with SUD. The intermediate-type was more prevalent in the SUD group, while a higher percentage of morning-type patients was found in the SUD + MDD. Sleep quality (including latency and daytime dysfunction) was worse for SUD + MDD patients than for SUD even after controlling age and age of SUD onset variables. Last, QOL was poorer in patients with SUD + MDD and, for them, psychological health had a negative relationship with SJL and severity of depression.Conclusions: Our data support and extend previous findings indicating that SUD + MDD is associated with worse clinical characteristics, more sleep problems, and poorer QOL than SUD patients. These results underline the importance of a precise assessment of these measurements in future studies conducted in SUD patients with/without MDD comorbidity that could be considered from a therapeutic point of view.
Circadian characteristics in patients under treatment for substance use disorders and severe mental illness (Schizophrenia, major depression and bipolar disorder) Ana Belén Serrano-Serrano, Julia E. Marquez-Arrico, José Francisco Navarro, Antonio Martinez-Nicolas, Ana Adan Journal of Clinical Medicine, 2021 Dual disorders (substance use and mental illness comorbidity) are a condition that has been strongly associated with severe symptomatology and clinical complications. The study of circadian characteristics in patients with Severe Mental Illness or Substance Use Disorder (SUD) has shown that such variables are related with mood symptoms and worse recovery. In absence of studies about circadian characteristics in patients with dual disorders we examined a sample of 114 male participants with SUD and comorbid Schizophrenia (SZ+; n = 38), Bipolar Disorder (BD+; n = 36) and Major Depressive Disorder (MDD+; n = 40). The possible differences in the sample of patients according to their psychiatric diagnosis, circadian functioning with recordings of distal skin temperature during 48 h (Thermochron iButton®), circadian typology and sleep-wake schedules were explored. MDD+ patients were more morning-type, while SZ+ and BD+ had an intermediate-type; the morning-type was more frequent among participants under inpatient SUD treatment. SZ+ patients had the highest amount of sleeping hours, lowest arousal and highest drowsiness followed by BD+ and MDD+, respectively. These observed differences suggest that treatment for patients with dual disorders could include chronobiological strategies to help them synchronize patterns with the day-light cycle, since morning-type is associated with better outcomes and recovery.
Circadian Rhythm and Substance Use in Adults: A Scoping Review of Sex-Based Differences JE Marquez-Arrico, A Adan Current Addiction Reports 13 (1), 36 , 2026 2026
Paper de la coordinació entre les assignatures de Psicobiologia en l’increment de l'interès de l’alumnat: Una anàlisi mediacional A Adan Puig, X Caldú i Ferrús, I Clemente, MJ Corral, J Costa Faidella, ... Congrés Internacional de Docència Universitària i Innovació (CIDUI) , 2025 2025
Paper de la Coordinació entre les Assignatures de Psicobiologia en l’Increment de l'Interès de l’Alumnat: Una Anàlisi Mediacional: Impacte de la Coordinació en l'Interès A Adan, X Caldú, I Clemente, MJ Corral, J Costa, J Domínguez-Borràs, ... Revista del Congrés Internacional de Docència Universitària i Innovació (CIDUI) , 2025 2025
Neurocognitive and clinical profile of male patients with substance use disorder in early remission phase with and without comorbid depression JE Marquez-Arrico, J Catalán-Aguilar, JF Navarro, A Adan Progress in Neuro-Psychopharmacology and Biological Psychiatry 134, 111085 , 2024 2024 Citations: 3
Could Periodontitis Increase the Risk of Suffering from Pancreatic Cancer?—A Systematic Review CF Márquez-Arrico, FJ Silvestre, JE Marquez-Arrico, J Silvestre-Rangil Cancers 16 (7), 1257 , 2024 2024 Citations: 7
Circadian rhythmicity in schizophrenia male patients with and without substance use disorder comorbidity A Adan, JE Marquez-Arrico, L Río-Martínez, JF Navarro, ... European Archives of Psychiatry and Clinical Neuroscience 274 (2), 279-290 , 2024 2024 Citations: 20
Circadian rhythmicity in schizophrenia male patients with and without substance use disorder comorbidity A Adan Puig, JE Marquez Arrico, L Río Martínez, JF Navarro, ... Springer Verlag , 2024 2024
Casos clínics psicofarmacologia. Grau de Psicologia Universitat de Barcelona. A Adan Puig, JE Marquez Arrico, JJ Soriano Raya, E Bedoya 2023
Neuropsychological functioning of patients with major depression or bipolar disorder comorbid to substance use disorders: A systematic review N Miguel, JE Marquez-Arrico, M Jodar, JF Navarro, A Adan European Neuropsychopharmacology 75, 41-58 , 2023 2023 Citations: 33
Neuropsychological performance in male patients with dual schizophrenia: influence on the clinical course at one year follow-up JE Marquez-Arrico, A Adan, JF Navarro Neuroscience Applied 2, 103393 , 2023 2023
Distal skin temperature in patients with substance use disorder: exploring sex-related differences in circadian parameters JE Marquez-Arrico, N Miguel, M Jodar, A Adan Neuroscience Applied 2, 102713 , 2023 2023
Patients with schizophrenia showed worse cognitive performance than bipolar and major depressive disorder in a sample with comorbid substance use disorders JE Marquez-Arrico, A Gonzalez-Sanchez, JF Navarro, R Penadés, ... Journal of Clinical Medicine 11 (22), 6648 , 2022 2022 Citations: 11
Circadian functioning and quality of life in substance use disorder patients with and without comorbid major depressive disorder I Hashemzadeh, JE Marquez-Arrico, K Hashemzadeh, JF Navarro, ... Frontiers in Psychiatry 12, 750500 , 2021 2021 Citations: 15
Circadian characteristics in patients under treatment for substance use disorders and severe mental illness (schizophrenia, major depression and bipolar disorder) AB Serrano-Serrano, JE Marquez-Arrico, JF Navarro, A Martinez-Nicolas, ... Journal of Clinical Medicine 10 (19), 4388 , 2021 2021 Citations: 29
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review G Prat, JE Marquez-Arrico, L Rio-Martinez, JF Navarro, A Adan Progress in Neuro-Psychopharmacology and Biological Psychiatry 110, 110310 , 2021 2021 Citations: 14
Progress in Neuropsychopharmacology & Biological Psychiatry DM Baur, D Lange, EM Elmenhorst, D Elmenhorst, A Bauer, D Aeschbach, ... 2021 Citations: 1
Health-related quality of life in male patients under treatment for substance use disorders with and without major depressive disorder: influence in clinical course at one-year … JE Marquez-Arrico, JF Navarro, A Adan Journal of clinical medicine 9 (10), 3110 , 2020 2020 Citations: 31
Temperament and character profile and its clinical correlates in male patients with dual schizophrenia L Río-Martínez, JE Marquez-Arrico, G Prat, A Adan Journal of clinical medicine 9 (6), 1876 , 2020 2020 Citations: 25
Coping strategies in male patients under treatment for substance use disorders and/or severe mental illness: influence in clinical course at one-year follow-up JE Marquez-Arrico, L Río-Martínez, JF Navarro, G Prat, DA Forero, ... Journal of Clinical Medicine 8 (11), 1972 , 2019 2019 Citations: 33
Personality profile and clinical correlates of patients with substance use disorder with and without comorbid depression under treatment JE Marquez-Arrico, L Río-Martínez, JF Navarro, G Prat, A Adan Frontiers in psychiatry 9, 764 , 2019 2019 Citations: 24
MOST CITED SCHOLAR PUBLICATIONS
Strategies to cope with treatment in substance use disorder male patients with and without schizophrenia JE Marquez-Arrico, I Benaiges, A Adan Psychiatry research 228 (3), 752-759 , 2015 2015 Citations: 76
Comparison of health-related quality of life among men with different co-existing severe mental disorders in treatment for substance use A Adan, JE Marquez-Arrico, G Gilchrist Health and Quality of Life Outcomes 15 (1), 209 , 2017 2017 Citations: 46
A systematic review and meta-analysis of psychosocial interventions to reduce drug and sexual blood borne virus risk behaviours among people who inject drugs G Gilchrist, D Swan, K Widyaratna, JE Marquez-Arrico, E Hughes, ... AIDS and Behavior 21 (7), 1791-1811 , 2017 2017 Citations: 39
Patología dual y rasgos de personalidad: situación actual y líneas futuras de trabajo JE Marquez-Arrico, A Adan Adicciones 25 (3), 195-202 , 2013 2013 Citations: 34
Neuropsychological functioning of patients with major depression or bipolar disorder comorbid to substance use disorders: A systematic review N Miguel, JE Marquez-Arrico, M Jodar, JF Navarro, A Adan European Neuropsychopharmacology 75, 41-58 , 2023 2023 Citations: 33
Coping strategies in male patients under treatment for substance use disorders and/or severe mental illness: influence in clinical course at one-year follow-up JE Marquez-Arrico, L Río-Martínez, JF Navarro, G Prat, DA Forero, ... Journal of Clinical Medicine 8 (11), 1972 , 2019 2019 Citations: 33
Health-related quality of life in male patients under treatment for substance use disorders with and without major depressive disorder: influence in clinical course at one-year … JE Marquez-Arrico, JF Navarro, A Adan Journal of clinical medicine 9 (10), 3110 , 2020 2020 Citations: 31
Circadian characteristics in patients under treatment for substance use disorders and severe mental illness (schizophrenia, major depression and bipolar disorder) AB Serrano-Serrano, JE Marquez-Arrico, JF Navarro, A Martinez-Nicolas, ... Journal of Clinical Medicine 10 (19), 4388 , 2021 2021 Citations: 29
Temperament and character dimensions in male patients with substance use disorders: Differences relating to psychiatric comorbidity JE Marquez-Arrico, S Lopez-Vera, G Prat, A Adan Psychiatry research 237, 1-8 , 2016 2016 Citations: 26
Temperament and character profile and its clinical correlates in male patients with dual schizophrenia L Río-Martínez, JE Marquez-Arrico, G Prat, A Adan Journal of clinical medicine 9 (6), 1876 , 2020 2020 Citations: 25
Personality profile and clinical correlates of patients with substance use disorder with and without comorbid depression under treatment JE Marquez-Arrico, L Río-Martínez, JF Navarro, G Prat, A Adan Frontiers in psychiatry 9, 764 , 2019 2019 Citations: 24
Circadian rhythmicity in schizophrenia male patients with and without substance use disorder comorbidity A Adan, JE Marquez-Arrico, L Río-Martínez, JF Navarro, ... European Archives of Psychiatry and Clinical Neuroscience 274 (2), 279-290 , 2024 2024 Citations: 20
Personality in patients with substance use disorders according to the co-occurring severe mental illness: A study using the alternative five factor model JE Marquez-Arrico, A Adan Personality and Individual Differences 97, 76-81 , 2016 2016 Citations: 18
Circadian functioning and quality of life in substance use disorder patients with and without comorbid major depressive disorder I Hashemzadeh, JE Marquez-Arrico, K Hashemzadeh, JF Navarro, ... Frontiers in Psychiatry 12, 750500 , 2021 2021 Citations: 15
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review G Prat, JE Marquez-Arrico, L Rio-Martinez, JF Navarro, A Adan Progress in Neuro-Psychopharmacology and Biological Psychiatry 110, 110310 , 2021 2021 Citations: 14
Patients with schizophrenia showed worse cognitive performance than bipolar and major depressive disorder in a sample with comorbid substance use disorders JE Marquez-Arrico, A Gonzalez-Sanchez, JF Navarro, R Penadés, ... Journal of Clinical Medicine 11 (22), 6648 , 2022 2022 Citations: 11
Could Periodontitis Increase the Risk of Suffering from Pancreatic Cancer?—A Systematic Review CF Márquez-Arrico, FJ Silvestre, JE Marquez-Arrico, J Silvestre-Rangil Cancers 16 (7), 1257 , 2024 2024 Citations: 7
Neurocognitive and clinical profile of male patients with substance use disorder in early remission phase with and without comorbid depression JE Marquez-Arrico, J Catalán-Aguilar, JF Navarro, A Adan Progress in Neuro-Psychopharmacology and Biological Psychiatry 134, 111085 , 2024 2024 Citations: 3
Progress in Neuropsychopharmacology & Biological Psychiatry DM Baur, D Lange, EM Elmenhorst, D Elmenhorst, A Bauer, D Aeschbach, ... 2021 Citations: 1
Circadian Rhythm and Substance Use in Adults: A Scoping Review of Sex-Based Differences JE Marquez-Arrico, A Adan Current Addiction Reports 13 (1), 36 , 2026 2026
